Search CORE

4 research outputs found

Treatment of systemic lupus erythematosus patients with the BAFF antagonist “peptibody” blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials

Author: A Becker-Merok
A Sutherland
Arunan Kaliyaperumal
AS Korganow
B Huard
B Schiemann
BH Rovin
Blaire Cooke
C Bossen
C Collins
C Jacob
C Pena-Rossi
C Reinsch
D Wallace
DA Isenberg
Daniel J. Wallace
Debra J. Zack
Donna Holloway
E Tan
Ellen M. Ginzler
Erik Rasmussen
F Mackay
G Cheema
H Hsu
J Groom
J Gross
J Gross
J Thompson
J Zhang
Jill Buyon
Joan T. Merrill
John Ferbas
JT Merrill
Kameswara Rao Kuchimanchi
KP Baker
L Ng
M Batten
M Dall’Era
M Hochberg
M Petri
M Ramanujam
Michael H. Weisman
N Kayagaki
P Tak
R Do
R Furie
R Looney
R. John Looney
S Belouski
S Hong
S Ju
S Khare
S Navarra
S Sato
Shelley S. Belouski
Tsui Chern Cheah
W Stohl
W Stohl
W Stohl
Wayne Tsuji
William Stohl
X Zhou
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Cartilaginous Metaplasia in Calcific Aortic Valve Disease

Author: Debra A. Groom
William R. Starke
Publication venue: 'Oxford University Press (OUP)'
Publication date
Field of study

Auer Rod-like Inclusions in Circulating Lymphoma Cells

Author: Debra A. Groom
Donna Wong
Linda K. Macaulay
Russell K. Brynes
Publication venue: 'Oxford University Press (OUP)'
Publication date
Field of study

B-cell activating factor (BAFF) is elevated in Chronic Granulomatous Disease

core

core